BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18466796)

  • 1. [Immune-mediated inflammatory diseases and psoriasis].
    Delaporte E
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 4():S269-74. PubMed ID: 18466796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psoriasis and inflammatory bowel diseases].
    Delaporte E
    Ann Dermatol Venereol; 2012 Apr; 139 Suppl 2():S46-52. PubMed ID: 22541728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: genetic associations and immune system changes.
    Liu Y; Krueger JG; Bowcock AM
    Genes Immun; 2007 Jan; 8(1):1-12. PubMed ID: 17093502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic role of tissue-resident immune cells in psoriasis.
    Boyman O; Conrad C; Tonel G; Gilliet M; Nestle FO
    Trends Immunol; 2007 Feb; 28(2):51-7. PubMed ID: 17197238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells in psoriasis.
    Tobin AM; Lynch L; Kirby B; O'Farrelly C
    J Innate Immun; 2011; 3(4):403-10. PubMed ID: 21613780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis.
    Döcke WD; Asadullah K; Belbe G; Ebeling M; Höflich C; Friedrich M; Sterry W; Volk HD
    J Leukoc Biol; 2009 Mar; 85(3):582-93. PubMed ID: 19038787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and therapy of psoriasis.
    Lowes MA; Bowcock AM; Krueger JG
    Nature; 2007 Feb; 445(7130):866-73. PubMed ID: 17314973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis, innate immunity, and gene pools.
    Bos JD
    J Am Acad Dermatol; 2007 Mar; 56(3):468-71. PubMed ID: 17317489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis associated with ulcerative colitis and Crohn's disease.
    Cohen AD; Dreiher J; Birkenfeld S
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.
    Ding C; Xu J; Li J
    Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for mast cells in psoriasis?
    Harvima IT; Nilsson G; Suttle MM; Naukkarinen A
    Arch Dermatol Res; 2008 Oct; 300(9):461-78. PubMed ID: 18719932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond tumor necrosis factor: next-generation biologic therapy for inflammatory bowel disease.
    Podolsky DK
    Dig Dis; 2009; 27(3):366-9. PubMed ID: 19786766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: new insight about pathogenesis, role of barrier organ integrity, NLR / CATERPILLER family genes and microbial flora.
    Mattozzi C; Richetta AG; Cantisani C; Macaluso L; Calvieri S
    J Dermatol; 2012 Sep; 39(9):752-60. PubMed ID: 22698089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.